Keywords
Human rabies
Rabies vaccine
Dog bite
Abstract
Rabies is a zoonotic viral disease transmitted mainly by bites of infected animals, especially dogs, which are responsible for 99% of human cases. Despite being preventable, it remains a neglected disease in low-income countries, with approximately 60,000 deaths per year, mostly concentrated in Africa and Asia. The real worldwide burden of rabies is probably underestimated, as death-reporting systems are inadequate and active surveillance is limited.
Rabies prevention implies two main, non-exclusive strategies: (i) dog vaccination, in order to interrupt virus transmission to humans, and (ii) human vaccination i.e. pre-exposure prophylaxis (PrEP) and PEP through the use of purified cell-culture and embryonated egg-based vaccines (CCEEVs).
Rabipur® is one of the available anti-rabies vaccines and is indicated for active immunization in individuals of all ages. Its efficacy and safety have been amply demonstrated.
In rabies-free countries, PrEP is indicated for individuals who face occupational and/or travel-related exposure to the rabies virus in specific settings or over an extended period.
Wider use of human rabies vaccination for PrEP and PEP in conjunction with programs to eradicate rabies from animal populations would be the right direction in reducing the burden of disease and achieving zero rabies, a challenging goal.
References
WHO Rabies. Available at https://www.who.int/news-room/fact-sheets/detail/rabies (Accessed on April 3 2024).
Noah DL, Drenzek CL, Smith JS, Krebs JW, Orciari L, Shaddock J, Sanderlin D, Whitfield S, Fekadu M, Olson JG, Rupprecht CE, Childs JE. Epidemiology of human rabies in the United States, 1980 to 1996. Ann Intern Med. 1998 Jun 1;128(11):922-30. doi: 10.7326/0003-4819-128-11-199806010-00012.
Giesen A, Gniel D, Malerczyk C. Correction to: 30 years of rabies vaccination with Rabipur: a summary of clinical data and global experience. Expert Rev Vaccines. 2015 May;14(5):775. doi: 10.1586/14760584.2015.1027863.
Coulon P, Derbin C, Kucera P, Lafay F, Prehaud C, Flamand A. Invasion of the peripheral nervous systems of adult mice by the CVS strain of rabies virus and its avirulent derivative AvO1. J Virol. 1989 Aug;63(8):3550-4. doi: 10.1128/JVI.63.8.3550-3554.1989.
Jackson AC, Phelan CC, Rossiter JP. Infection of Bergmann glia in the cerebellum of a skunk experimentally infected with street rabies virus. Can J Vet Res. 2000 Oct;64(4):226-8.
Lippi G, Cervellin G. Updates on Rabies virus disease: is evolution toward "Zombie virus" a tangible threat? Acta Biomed. 2021 Feb 4;92(1):e2021045. doi: 10.23750/abm.v92i1.9153.
World Health Organization. WHO Expert Consultation on Rabies: third report. Geneva: World Health Organization; 2018 (Accessed on August 12 2024).
Scott TP, Nel LH. Lyssaviruses and the Fatal Encephalitic Disease Rabies. Front Immunol. 2021 Dec 2;12:786953. doi: 10.3389/fimmu.2021.786953.
Marston DA, Banyard AC, McElhinney LM, Freuling CM, Finke S, de Lamballerie X, Müller T, Fooks AR. The lyssavirus host-specificity conundrum-rabies virus-the exception not the rule. Curr Opin Virol. 2018 Feb;28:68-73. doi: 10.1016/j.coviro.2017.11.007.
Ness A, Aiken J, McKenzie D. Sheep scrapie and deer rabies in England prior to 1800. Prion. 2023 Dec;17(1):7-15. doi: 10.1080/19336896.2023.2166749.
Wiktor TJ, György E, Schlumberger D, Sokol F, Koprowski H. Antigenic properties of rabies virus components. J Immunol. 1973 Jan;110(1):269-76.
Gaudin Y, Ruigrok RW, Tuffereau C, Knossow M, Flamand A. Rabies virus glycoprotein is a trimer. Virology. 1992 Apr;187(2):627-32. doi: 10.1016/0042-6822(92)90465-2.
Lian M, Hueffer K, Weltzin MM. Interactions between the rabies virus and nicotinic acetylcholine receptors: A potential role in rabies virus induced behavior modifications. Heliyon. 2022 Aug 28;8(9):e10434. doi: 10.1016/j.heliyon.2022.e10434.
Hemachudha T, Laothamatas J, Rupprecht CE. Human rabies: a disease of complex neuropathogenetic mechanisms and diagnostic challenges. Lancet Neurol. 2002 Jun;1(2):101-9. doi: 10.1016/s1474-4422(02)00041-8.
Ray NB, Ewalt LC, Lodmell DL. Rabies virus replication in primary murine bone marrow macrophages and in human and murine macrophage-like cell lines: implications for viral persistence. J Virol. 1995 Feb;69(2):764-72. doi: 10.1128/JVI.69.2.764-772.1995.
Mitrabhakdi E, Shuangshoti S, Wannakrairot P, Lewis RA, Susuki K, Laothamatas J, Hemachudha T. Difference in neuropathogenetic mechanisms in human furious and paralytic rabies. J Neurol Sci. 2005 Nov 15;238(1-2):3-10. doi: 10.1016/j.jns.2005.05.004.
Mader EC Jr, Maury JS, Santana-Gould L, Craver RD, El-Abassi R, Segura-Palacios E, Sumner AJ. Human Rabies with Initial Manifestations that Mimic Acute Brachial Neuritis and Guillain-Barré Syndrome. Clin Med Insights Case Rep. 2012;5:49-55. doi: 10.4137/CCRep.S9318.
Hemachudha T, Phuapradit P. Rabies. Curr Opin Neurol. 1997 Jun;10(3):260-7. doi: 10.1097/00019052-199706000-00016.
Hemachudha T, Wacharapluesadee S, Laothamatas J, Wilde H. Rabies. Curr Neurol Neurosci Rep. 2006 Nov;6(6):460-8. doi: 10.1007/s11910-006-0047-2.
Centers for Disease Control and Prevention (CDC). Human rabies--Minnesota, 2007. MMWR Morb Mortal Wkly Rep. 2008 May 2;57(17):460-2.
Shantavasinkul P, Tantawichien T, Wacharapluesadee S, Jeamanukoolkit A, Udomchaisakul P, Chattranukulchai P, Wongsaroj P, Khawplod P, Wilde H, Hemachudha T. Failure of rabies postexposure prophylaxis in patients presenting with unusual manifestations. Clin Infect Dis. 2010 Jan 1;50(1):77-9. doi: 10.1086/649873.
Smreczak M, Orłowska A, Trębas P, Stolarek A, Freuling C, Müller T. Re-emergence of rabies in Mazowieckie Voivodeship, Poland, 2021. Zoonoses Public Health. 2023 Feb;70(1):111-116. doi: 10.1111/zph.13005.
Knobel DL, Cleaveland S, Coleman PG, Fèvre EM, Meltzer MI, Miranda ME, Shaw A, Zinsstag J, Meslin FX. Re-evaluating the burden of rabies in Africa and Asia. Bull World Health Organ. 2005 May;83(5):360-8.
Taylor LH, Hampson K, Fahrion A, Abela-Ridder B, Nel LH. Difficulties in estimating the human burden of canine rabies. Acta Trop. 2017 Jan;165:133-140. doi: 10.1016/j.actatropica.2015.12.007.
Ma X, Bonaparte S, Toro M, Orciari LA, Gigante CM, Kirby JD, Chipman RB, Fehlner-Gardiner C, Cedillo VG, Aréchiga-Ceballos N, Rao AK, Petersen BW, Wallace RM. Rabies surveillance in the United States during 2020. J Am Vet Med Assoc. 2022 May 5;260(10):1157-1165. doi: 10.2460/javma.22.03.0112.
Subedi D, Chandran D, Subedi S, Acharya KP. Ecological and Socioeconomic Factors in the Occurrence of Rabies: A Forgotten Scenario. Infect Dis Rep. 2022 Dec 1;14(6):979-986. doi: 10.3390/idr14060097.
CDC. Rabies. CDC Yellow Book 2024. Available at https://wwwnc.cdc.gov/travel/yellowbook/2024/infections-diseases/rabies. (Accessed on July 24 2024).
Velasco-Villa A, Mauldin MR, Shi M, Escobar LE, Gallardo-Romero NF, Damon I, Olson VA, Streicker DG, Emerson G. The history of rabies in the Western Hemisphere. Antiviral Res. 2017 Oct;146:221-232. doi: 10.1016/j.antiviral.2017.03.013.
WHO's Strategic Advisory Group of Experts (SAGE) on Immunization, meeting of October 2017. Rabies session. Recommendations: http://www.who.int/immunization/sage/meetings/2017/october/presentations_background_docs/en/index1.html. See also ‘Background paper: Proposed Revision of the Policy on Rabies Vaccines and Rabies Immunoglobulins’ in: SAGE meeting of October 2017, Background documents. Session: Rabies vaccines. http://www.who.int/immunization/sage/meetings/2017/october/presentations_background_docs/en/. (link sopra indicati non funzionano. Solo questo è raggiungibile: https://www.who.int/news-room/events/detail/2017/10/17/default-calendar/strategic-advisory-group-of-experts-on-immunization-(sage)---october-2017.
Hampson K, Coudeville L, Lembo T, Sambo M, Kieffer A, Attlan M, Barrat J, Blanton JD, Briggs DJ, Cleaveland S, Costa P, Freuling CM, Hiby E, Knopf L, Leanes F, Meslin FX, Metlin A, Miranda ME, Müller T, Nel LH, Recuenco S, Rupprecht CE, Schumacher C, Taylor L, Vigilato MA, Zinsstag J, Dushoff J; Global Alliance for Rabies Control Partners for Rabies Prevention. Estimating the global burden of endemic canine rabies. PLoS Negl Trop Dis. 2015 Apr 16;9(4):e0003709. doi: 10.1371/journal.pntd.0003709. Erratum in: PLoS Negl Trop Dis. 2015 May 11;9(5):e0003786. doi: 10.1371/journal.pntd.0003786.
Arief RA, Hampson K, Jatikusumah A, Widyastuti MD, Sunandar, Basri C, Putra AA, Willyanto I, Estoepangestie AT, Mardiana IW, Kesuma IK, Sumantra IP, Doherty PF Jr, Salman MD, Gilbert J, Unger F. Determinants of Vaccination Coverage and Consequences for Rabies Control in Bali, Indonesia. Front Vet Sci. 2017 Jan 9;3:123. doi: 10.3389/fvets.2016.00123. Erratum in: Front Vet Sci. 2017 Feb 22;4:20. doi: 10.3389/fvets.2017.00020.
Tan J, Wang R, Ji S; Nanjing Agricultural University research group of The Challenge Cup Rabies Research Group; Su S, Zhou J. One Health strategies for rabies control in rural areas of China. Lancet Infect Dis. 2017 Apr;17(4):365-367. doi: 10.1016/S1473-3099(17)30116-0.
Fang LX, Ping F, Ping du Y, Hui BG, Yan YX. Socioeconomic status is a critical risk factor for human rabies post-exposure prophylaxis. Vaccine. 2010 Oct 4;28(42):6847-51. doi: 10.1016/j.vaccine.2010.08.034.
Arias-Orozco P, Bástida-González F, Cruz L, Villatoro J, Espinoza E, Zárate-Segura PB, Recuenco S. Spatiotemporal analysis of canine rabies in El Salvador: Violence and poverty as social factors of canine rabies. PLoS One. 2018 Aug 17;13(8):e0201305. doi: 10.1371/journal.pone.0201305.
Fisher CR, Streicker DG, Schnell MJ. The spread and evolution of rabies virus: conquering new frontiers. Nat Rev Microbiol. 2018 Apr;16(4):241-255. doi: 10.1038/nrmicro.2018.11.
Kunkel A, Jeon S, Joseph HC, Dilius P, Crowdis K, Meltzer MI, Wallace R. The urgency of resuming disrupted dog rabies vaccination campaigns: a modeling and cost-effectiveness analysis. Sci Rep. 2021 Jun 14;11(1):12476. doi: 10.1038/s41598-021-92067-5.
Fehlner-Gardiner C. Rabies control in North America - past, present and future. Rev Sci Tech. 2018 Aug;37(2):421-437. English. doi: 10.20506/rst.37.2.2812.
Brunt S, Solomon H, Brown K, Davis A. Feline and Canine Rabies in New York State, USA. Viruses. 2021;13:450. doi: 10.3390/v13030450.
Moore SM. Rabies: Current Preventive Strategies. Vet Clin North Am Small Anim Pract. 2019 Jul;49(4):629-641. doi: 10.1016/j.cvsm.2019.02.014.
WHO Rabies epidemiology. Available at: https://www.who.int/teams/control-of-neglected-tropical-diseases/rabies/epidemiology-and-burden#:~:text=Rabies%20is%20estimated%20to%20cause,the%20true%20burden%20of%20disease. (Accessed on August 3 2024).
Rupprecht CE, Hanlon CA, Hemachudha T. Rabies re-examined. Lancet Infect Dis. 2002 Jun;2(6):327-43. doi: 10.1016/s1473-3099(02)00287-6.
Marston DA, Horton DL, Nunez J, Ellis RJ, Orton RJ, Johnson N, Banyard AC, McElhinney LM, Freuling CM, Fırat M, Ünal N, Müller T, de Lamballerie X, Fooks AR. Genetic analysis of a rabies virus host shift event reveals within-host viral dynamics in a new host. Virus Evol. 2017 Dec 13;3(2):vex038. doi: 10.1093/ve/vex038.
GBD Results. Available at https://vizhub.healthdata.org/gbd-results/. (Accessed on May 25 2024).
Gan H, Hou X, Wang Y, Xu G, Huang Z, Zhang T, Lin R, Xue M, Hu H, Liu M, Cheng ZJ, Zhu Z, Sun B. Global burden of rabies in 204 countries and territories, from 1990 to 2019: results from the Global Burden of Disease Study 2019. Int J Infect Dis. 2023 Jan;126:136-144. doi: 10.1016/j.ijid.2022.10.046.
Qin X, Liu K, Fu T, Song S, Zhao C, Li Z, Lu X, Shao Z. Global burden, trends, and predictions of rabies: an analysis from the Global Burden of Disease Study 1990–2019 and projections for 2030. Journal of Public Health. https://doi.org/10.1007/s10389-023-01971-9.
WHO Rabies Modelling Consortium. Zero human deaths from dog-mediated rabies by 2030: perspectives from quantitative and mathematical modelling. Gates Open Res. 2020 Mar 4;3:1564. doi: 10.12688/gatesopenres.13074.2.
WHO. African Region. Rabies preventable human death. Analytical Fact Sheet . 2023. https://files.aho.afro.who.int/afahobckpcontainer/production/files/Regional_Rabies_fact_sheet_Nov23.pdf.
PAHO. PAN American Health Organization. World Rabies Day: Latin America and the Caribbean on the cusp of eliminating rabies deaths. Available at: https://www.paho.org/en/news/25-9-2018-world-rabies-day-latin-america-and-caribbean-cusp-eliminating-rabies-deaths. (Accessed on June 6 2024).
ECDC. The European Union One Health Zoonoses Report 2022. EFSA Journal. 2023;21:e8442. https://doi.org/10.2903/j.efsa.2023.8442.
Rabipur. https://ec.europa.eu/health/documents/community-register/2021/20211215154223/anx_154223_it.pdf. Questo link porta ad un file .pdf dove si parla del prodotto Rabitec (vaccino per animali) non Rabipur
CDC ACIP. ACIP Evidence to Recommendations for Rabies Pre-exposure prophylaxis with a 2-dose Schedule. Available at: https://www.cdc.gov/acip/evidence-to-recommendations/rabies-2-dose-etr.html?CDC_AAref_Val=https://www.cdc.gov/vaccines/acip/recs/grade/rabies-2-dose-etr.html. (Accessed on July 7 2024).
Vodopija I, Sureau P, Lafon M, Baklaic Z, Ljubicić M, Svjetlicić M, Smerdel S. An evaluation of second generation tissue culture rabies vaccines for use in man: a four-vaccine comparative immunogenicity study using a pre-exposure vaccination schedule and an abbreviated 2-1-1 postexposure schedule. Vaccine. 1986 Dec;4(4):245-8. doi: 10.1016/0264-410x(86)90138-6.
Nicholson KG, Farrow PR, Bijok U, Barth R. Pre-exposure studies with purified chick embryo cell culture rabies vaccine and human diploid cell vaccine: serological and clinical responses in man. Vaccine. 1987 Sep;5(3):208-10. doi: 10.1016/0264-410x(87)90102-2.
Dreesen DW, Fishbein DB, Kemp DT, Brown J. Two-year comparative trial on the immunogenicity and adverse effects of purified chick embryo cell rabies vaccine for pre-exposure immunization. Vaccine. 1989 Oct;7(5):397-400. doi: 10.1016/0264-410x(89)90152-7.
Jaijaroensup W, Limusanno S, Khawplod P, Serikul K, Chomchay P, Kaewchomphoo W, Tantawichien T, Wilde H. Immunogenicity of rabies postexposure booster injections in subjects who had previously received intradermal preexposure vaccination. J Travel Med. 1999 Dec;6(4):234-7. doi: 10.1111/j.1708-8305.1999.tb00524.x.
Cramer JP, Jelinek T, Paulke-Korinek M, Reisinger EC, Dieckmann S, Alberer M, Bühler S, Bosse D, Meyer S, Fragapane E, Costantini M, Pellegrini M, Lattanzi M, Dovali C. One-year immunogenicity kinetics and safety of a purified chick embryo cell rabies vaccine and an inactivated Vero cell-derived Japanese encephalitis vaccine administered concomitantly according to a new, 1-week, accelerated primary series. J Travel Med. 2016 Mar 19;23(3):taw011. doi: 10.1093/jtm/taw011.
Overduin LA, Koopman JPR, Prins C, Verbeek-Menken PH, De Pijper CA, Eblé PL, Heerink F, van Genderen PJJ, Grobusch MP, Visser LG. Boostability after single-visit pre-exposure prophylaxis with rabies vaccine: a randomised controlled non-inferiority trial. Lancet Infect Dis. 2024 Feb;24(2):206-216. doi: 10.1016/S1473-3099(23)00452-8.
Garcia Garrido HM, van Put B, Terryn S, de Pijper CA, Stijnis C, D'Haens GR, Spuls PI, van de Sande MG, van Gucht S, Grobusch MP, Goorhuis A. Immunogenicity and 1-year boostability of a three-dose intramuscular rabies pre-exposure prophylaxis schedule in adults receiving immunosuppressive monotherapy: a prospective single-centre clinical trial. J Travel Med. 2023 Apr 5;30(2):taac148. doi: 10.1093/jtm/taac148.
Lumbiganon P, Chaiprasithikul P, Sookpranee T, Paholpak S, Wasi C. Pre-exposure vaccination with purified chick embryo cell rabies vaccines in children. Asian Pac J Allergy Immunol. 1989 Dec;7(2):99-101.
Pengsaa K, Limkittikul K, Sabchareon A, Ariyasriwatana C, Chanthavanich P, Attanath P, Malerczyk C. A three-year clinical study on immunogenicity, safety, and booster response of purified chick embryo cell rabies vaccine administered intramuscularly or intradermally to 12- to 18-month-old Thai children, concomitantly with Japanese encephalitis vaccine. Pediatr Infect Dis J. 2009 Apr;28(4):335-7. doi: 10.1097/INF.0b013e3181906351.
Sehgal S, Bhardwaj M, Bhattacharya D. Immunogenicity and feasibility of purified chick embryo cell vaccine. Indian Pediatr. 1994 Feb;31(2):133-7.
Lumbiganon P, Wasi C. Survival after rabies immunisation in newborn infant of affected mother. Lancet. 1990 Aug 4;336(8710):319. doi: 10.1016/0140-6736(90)91861-4.
Sudarshan MK, Giri MS, Mahendra BJ, Venkatesh GM, Sanjay TV, Narayana DH, Ravish HS. Assessing the safety of post-exposure rabies immunization in pregnancy. Hum Vaccin. 2007 May-Jun;3(3):87-9. doi: 10.4161/hv.3.3.4010.
Quiambao BP, Dimaano EM, Ambas C, Davis R, Banzhoff A, Malerczyk C. Reducing the cost of post-exposure rabies prophylaxis: efficacy of 0.1 ml PCEC rabies vaccine administered intradermally using the Thai Red Cross post-exposure regimen in patients severely exposed to laboratory-confirmed rabid animals. Vaccine. 2005 Feb 25;23(14):1709-14. doi: 10.1016/j.vaccine.2004.09.027.
Dobardzic A, Izurieta H, Woo EJ, Iskander J, Shadomy S, Rupprecht C, Ball R, Braun MM. Safety review of the purified chick embryo cell rabies vaccine: Data from the Vaccine Adverse Event Reporting System (VAERS), 1997-2005. Vaccine. 2007 May 22;25(21):4244-51. doi: 10.1016/j.vaccine.2007.02.075.
Scheiermann N, Baer J, Hilfenhaus J, Marcus I, Zoulek G. Reactogenicity and immunogenicity of the newly developed purified chick embryo cell (PCEC)-rabies vaccine in man. Zentralbl Bakteriol Mikrobiol Hyg A. 1987 Jul;265(3-4):439-50. doi: 10.1016/s0176-6724(87)80263-8.
Madhusudana SN, Tripathi KK. Post exposure studies with human diploid cell rabies vaccine and purified chick embryo cell vaccine: comparative serological responses in man. Zentralbl Bakteriol. 1989 Sep;271(3):345-50. doi: 10.1016/s0934-8840(89)80033-7.
Briggs DJ, Dreesen DW, Nicolay U, Chin JE, Davis R, Gordon C, Banzhoff A. Purified Chick Embryo Cell Culture Rabies Vaccine: interchangeability with Human Diploid Cell Culture Rabies Vaccine and comparison of one versus two-dose post-exposure booster regimen for previously immunized persons. Vaccine. 2000 Dec 8;19(9-10):1055-60. doi: 10.1016/s0264-410x(00)00342-x.
Bijok U, Vodopija I, Smerdel S, Thongcharoen P, Nicholson K, Dietrich M, Gonzalez de Cosio A. Purified chick embryo cell (PCEC) rabies vaccine for human use: clinical trials. Behring Inst Mitt. 1984 Nov;(76):155-64.
Sehgal S, Bhattacharya D, Bhardwaj M. Ten year longitudinal study of efficacy and safety of purified chick embryo cell vaccine for pre- and post-exposure prophylaxis of rabies in Indian population. J Commun Dis. 1995 Mar;27(1):36-43.
WHO. WHO Expert Consultation on Rabies https://iris.who.int/bitstream/handle/10665/272364/9789241210218-eng.pdf.
NITAG. https://www.nitag-resource.org/sites/default/files/0cd83c26cce042fc02a514aa7c31e9616f281f46_1.pdf.
GOV.UK. Rabies post-exposure treatment: management guidelines. Available at: https://www.gov.uk/government/publications/rabies-post-exposure-prophylaxis-management-guidelines. (Accessed June 18 2024).
CDC. Rabies Post-exposure Prophylaxis. Available at: https://www.cdc.gov/rabies/hcp/prevention-recommendations/post-exposure-prophylaxis.html. Accessed June 20 2024.
Canada. Rabies Vaccinee: Canadian Immunization Guide. Available at: https://www.canada.ca/en/public-health/services/publications/healthy-living/canadian-immunization-guide-part-4-active-vaccines/page-18-rabies-vaccine.html. (Accessed June 6 2024).
Hampson K. Good news for travellers, but what do rabies vaccines say about global health? Lancet Infect Dis. 2024 Feb;24(2):119-121. doi: 10.1016/S1473-3099(23)00499-1.
Gossner CM, Mailles A, Aznar I, Dimina E, Echevarría JE, Feruglio SL, Lange H, Maraglino FP, Parodi P, Perevoscikovs J, Van der Stede Y, Bakonyi T. Prevention of human rabies: a challenge for the European Union and the European Economic Area. Euro Surveill. 2020 Sep;25(38):2000158. doi: 10.2807/1560-7917.ES.2020.25.38.2000158.
Kan VL, Joyce P, Benator D, Agnes K, Gill J, Irmler M, Clark A, Giannakos G, Gabourel A, Gordin FM. Risk assessment for healthcare workers after a sentinel case of rabies and review of the literature. Clin Infect Dis. 2015 Feb 1;60(3):341-8. doi: 10.1093/cid/ciu850.
Khairullah AR, Kurniawan SC, Hasib A, Silaen OSM, Widodo A, Effendi MH, Ramandinianto SC, Moses IB, Riwu KHP, Yanestria SM. Tracking lethal threat: in-depth review of rabies. Open Vet J. 2023 Nov;13(11):1385-1399. doi: 10.5455/OVJ.2023.v13.i11.1.
Chikanya E, Macherera M, Maviza A. An assessment of risk factors for contracting rabies among dog bite cases recorded in Ward 30, Murewa district, Zimbabwe. PLoS Negl Trop Dis. 2021 Mar 31;15(3):e0009305. doi: 10.1371/journal.pntd.0009305.
WHO. New global strategic plan to eliminate dog-mediated rabies by 2030. Available at: https://www.who.int/news-room/commentaries/detail/new-global-strategic-plan-to-eliminate-dog-mediated-rabies-by-2030. (Accessed August 4 2024).
Shafaati M, Akbarpour S, Priyanka, Saied AA, Choudhary OP. Tackling rabies by one health approach: Pitfalls on the road to global eradication. New Microbes New Infect. 2023 Feb 4;52:101098. doi: 10.1016/j.nmni.2023.101098.